Instituto de Diagnostico SA operates within the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Instituto de Diagnostico SA with three other
health care providers in Latin America:
Hapvida Participacoes e Investimentos SA
sales of 8.55 billion Brazilian Reals [US$1.54 billion]
of which 100%
was Health Sector),
Clinica Las Condes SA
(212.27 billion Chilean Pesos [US$263.21 million]
of which 67%
was Hospital), and
Medica Sur S.A.B. de c.v.
based in MEXICO
(4.47 billion Mexican Pesos [US$220.94 million]
of which 60%
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Instituto de Diagnostico SA totalled
47.31 billion Chilean Pesos .
an increase of 71.8%
from the 27.55 billion Chilean Pesos in sales at the company during the second quarter of 2020.
This was the biggest same quarter rise in sales at Instituto de Diagnostico SA in the previous 35 quarters.
During the first two
quarters of 2021, sales totalled 91.54 billion Chilean Pesos , which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Instituto de Diagnostico SA were 139.36 billion Chilean Pesos (US$172.80 million).
decrease of 7.2%
versus 2019, when the company's sales were 150.19 billion Chilean Pesos .
Contributing to the drop in overall sales was the 22.4% decline
in Others, from 1.34 billion Chilean Pesos to 1.04 billion Chilean Pesos .
There were also decreases in sales in
Outpatient (down 22.1% to 42.05 billion Chilean Pesos )
However, these declines were partially offset by the increase in sales of
Hospitalization (up 1.4% to 97.42 billion Chilean Pesos )